GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Bangkok Lab and Cosmetic PCL (BKK:BLC) » Definitions » EV-to-EBIT

Bangkok Lab and Cosmetic PCL (BKK:BLC) EV-to-EBIT : 11.97 (As of May. 23, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Bangkok Lab and Cosmetic PCL EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Bangkok Lab and Cosmetic PCL's Enterprise Value is ฿2,485 Mil. Bangkok Lab and Cosmetic PCL's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ฿208 Mil. Therefore, Bangkok Lab and Cosmetic PCL's EV-to-EBIT for today is 11.97.

The historical rank and industry rank for Bangkok Lab and Cosmetic PCL's EV-to-EBIT or its related term are showing as below:

BKK:BLC' s EV-to-EBIT Range Over the Past 10 Years
Min: 9.21   Med: 11.17   Max: 27.38
Current: 11.97

During the past 3 years, the highest EV-to-EBIT of Bangkok Lab and Cosmetic PCL was 27.38. The lowest was 9.21. And the median was 11.17.

BKK:BLC's EV-to-EBIT is ranked better than
56.97% of 1485 companies
in the Consumer Packaged Goods industry
Industry Median: 13.75 vs BKK:BLC: 11.97

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Bangkok Lab and Cosmetic PCL's Enterprise Value for the quarter that ended in Mar. 2024 was ฿2,476 Mil. Bangkok Lab and Cosmetic PCL's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ฿208 Mil. Bangkok Lab and Cosmetic PCL's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 8.38%.


Bangkok Lab and Cosmetic PCL EV-to-EBIT Historical Data

The historical data trend for Bangkok Lab and Cosmetic PCL's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bangkok Lab and Cosmetic PCL EV-to-EBIT Chart

Bangkok Lab and Cosmetic PCL Annual Data
Trend Dec21 Dec22 Dec23
EV-to-EBIT
- - 10.68

Bangkok Lab and Cosmetic PCL Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only - 16.83 12.40 10.68 11.93

Competitive Comparison of Bangkok Lab and Cosmetic PCL's EV-to-EBIT

For the Household & Personal Products subindustry, Bangkok Lab and Cosmetic PCL's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bangkok Lab and Cosmetic PCL's EV-to-EBIT Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Bangkok Lab and Cosmetic PCL's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Bangkok Lab and Cosmetic PCL's EV-to-EBIT falls into.



Bangkok Lab and Cosmetic PCL EV-to-EBIT Calculation

Bangkok Lab and Cosmetic PCL's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=2484.689/207.572
=11.97

Bangkok Lab and Cosmetic PCL's current Enterprise Value is ฿2,485 Mil.
Bangkok Lab and Cosmetic PCL's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿208 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bangkok Lab and Cosmetic PCL  (BKK:BLC) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Bangkok Lab and Cosmetic PCL's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=207.572/2475.803
=8.38 %

Bangkok Lab and Cosmetic PCL's Enterprise Value for the quarter that ended in Mar. 2024 was ฿2,476 Mil.
Bangkok Lab and Cosmetic PCL's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿208 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bangkok Lab and Cosmetic PCL EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Bangkok Lab and Cosmetic PCL's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Bangkok Lab and Cosmetic PCL (BKK:BLC) Business Description

Traded in Other Exchanges
N/A
Address
Nong Chae Sao Road, No. 48/1 Moo 5, Nam Phu, Mueang Ratchaburi, Ratchaburi, Bangkok, THA, 70000
Bangkok Lab and Cosmetic PCL are one of Thailand's comprehensive healthcare solutions groups. Its operation covers the complete value chain of the healthcare business. Its product portfolio comprises generic and new generic drugs, herbal medicines, animal medicines, cosmetics, food supplements, and other health products. Its operation ranges from research and development, manufacturing with international standards, sales, and marketing, to distribution to partnering businesses and customers.

Bangkok Lab and Cosmetic PCL (BKK:BLC) Headlines

No Headlines